Invention Grant
- Patent Title: Crystalline salts of a potent HCV inhibitor
-
Application No.: US14621534Application Date: 2015-02-13
-
Publication No.: US09382240B2Publication Date: 2016-07-05
- Inventor: Bing-Shiou Yang , Ka Yip
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edward S. Lazer
- Main IPC: A61K31/47
- IPC: A61K31/47 ; C07D417/14
Abstract:
This invention relates to novel tris(hydroxymethyl)aminomethane, choline and N-methyl-D-glucamine salt forms of the following Compound (1) and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection:
Public/Granted literature
- US20150166530A1 Crystalline Salts of a Potent HCV Inhibitor Public/Granted day:2015-06-18
Information query
